1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF184 CTRPv2 pan-cancer AAC 0.23 6e-09
mRNA GRIK5 CTRPv2 pan-cancer AAC 0.21 6e-09
mRNA HCFC1 CTRPv2 pan-cancer AAC 0.23 7e-09
mRNA SPN CTRPv2 pan-cancer AAC 0.28 7e-09
mRNA SEPT5 CTRPv2 pan-cancer AAC 0.21 8e-09
mRNA CASP2 CTRPv2 pan-cancer AAC 0.22 8e-09
mRNA KIAA1147 CTRPv2 pan-cancer AAC 0.21 8e-09
mRNA WDR7 CTRPv2 pan-cancer AAC 0.22 9e-09
mRNA TMEM74 CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA TMSB15A CTRPv2 pan-cancer AAC 0.22 1e-08
Download CSV